- Home
- MQY vs IART Comparison
MQY vs IART Comparison
Compare MQY & IART Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MQY | IART |
|---|---|---|
| Founded | N/A | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 836.1M | 933.9M |
| IPO Year | 1994 | 1996 |
Fundamental Metrics
Financial Performance| Metric | MQY | IART |
|---|---|---|
| Price | $11.59 | $9.53 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $14.83 |
| AVG Volume (30 Days) | 311.0K | ★ 720.9K |
| Earning Date | 01-01-0001 | 05-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $4.45 |
| Revenue Next Year | N/A | $3.40 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $10.52 | $9.37 |
| 52 Week High | $11.97 | $24.37 |
Technical Indicators
Market Signals| Indicator | MQY | IART |
|---|---|---|
| Relative Strength Index (RSI) | 41.57 | 29.57 |
| Support Level | $11.49 | N/A |
| Resistance Level | $11.78 | $14.14 |
| Average True Range (ATR) | 0.10 | 0.54 |
| MACD | -0.03 | -0.18 |
| Stochastic Oscillator | 12.66 | 8.71 |
Price Performance
Historical ComparisonAbout MQY Blackrock MuniYield Quality Fund Inc.
Blackrock Muniyield Quality Fund Inc is a closed-end management investment company. The company's objective is to provide shareholders with as high a level of current income exempt from U.S. federal income taxes as is consistent with its investment policies and prudent investment management. The company invests in Transportation, Corporate, Health, Utilities, Education, Housing, and other sectors.
About IART Integra LifeSciences Holdings Corporation
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales.